Alivus Life Sciences Limited (NSE:ALIVUS)
India flag India · Delayed Price · Currency is INR
919.80
-2.85 (-0.31%)
At close: Feb 13, 2026

Alivus Life Sciences Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
112,893132,48195,16148,14156,215-
Market Cap Growth
-23.06%39.22%97.67%-14.36%--
Enterprise Value
106,969128,17890,91344,57052,405-
Last Close Price
919.801075.43772.54377.65408.52-
PE Ratio
20.8027.2820.2110.3113.43-
Forward PE
18.9723.1416.549.9611.60-
PS Ratio
4.495.554.172.232.65-
PB Ratio
3.744.704.082.252.74-
P/TBV Ratio
3.774.744.112.272.75-
P/FCF Ratio
-58.7933.4433.6212.08-
P/OCF Ratio
-33.8423.0115.739.41-
PEG Ratio
1.721.451.120.980.72-
EV/Sales Ratio
4.265.373.982.062.47-
EV/EBITDA Ratio
13.7818.8813.596.978.53-
EV/EBIT Ratio
15.0320.5514.617.429.05-
EV/FCF Ratio
-56.8831.9531.1211.26-
Debt / Equity Ratio
0.020.020.010.010.001.24
Debt / EBITDA Ratio
0.080.080.030.030.001.57
Debt / FCF Ratio
-0.250.060.140.012.91
Net Debt / Equity Ratio
-0.20-0.17-0.12-0.12-0.251.08
Net Debt / EBITDA Ratio
-0.77-0.72-0.42-0.41-0.831.37
Net Debt / FCF Ratio
--2.18-1.00-1.85-1.092.54
Asset Turnover
-0.760.820.840.951.01
Inventory Turnover
-1.691.641.872.072.02
Quick Ratio
-3.312.642.343.100.66
Current Ratio
-4.974.373.734.601.15
Return on Equity (ROE)
-18.86%21.07%22.28%29.83%60.91%
Return on Assets (ROA)
-12.45%14.01%14.52%16.20%18.86%
Return on Invested Capital (ROIC)
21.98%21.18%23.67%26.11%27.58%27.79%
Return on Capital Employed (ROCE)
-21.20%25.80%27.20%27.70%72.40%
Earnings Yield
4.82%3.67%4.95%9.70%7.45%-
FCF Yield
-1.70%2.99%2.97%8.28%-
Dividend Yield
0.54%0.46%2.91%5.56%5.14%-
Payout Ratio
--58.55%82.64%30.73%-
Buyback Yield / Dilution
-0.01%-0.17%-0.13%-4.25%-9.03%-
Total Shareholder Return
0.53%0.30%2.79%1.31%-3.89%-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.